Royal Bank of Canada’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-718
| Closed | -$13K | – | 7923 |
|
|
2020
Q4 | $13K | Sell |
718
-135
| -16% | -$1.89K | ﹤0.01% | 6282 |
|
|
2020
Q3 | $11K | Sell |
853
-41
| -5% | -$544 | ﹤0.01% | 5911 |
|
|
2020
Q2 | $11K | Buy |
894
+1
| +0.1% | +$12 | ﹤0.01% | 5815 |
|
|
2020
Q1 | $8K | Buy |
893
+165
| +23% | +$2.31K | ﹤0.01% | 5920 |
|
|
2019
Q4 | $12K | Buy |
728
+483
| +197% | +$7.83K | ﹤0.01% | 6092 |
|
|
2019
Q3 | $4K | Hold |
245
| – | – | ﹤0.01% | 6148 |
|
|
2019
Q2 | $3K | Buy |
245
+27
| +12% | +$413 | ﹤0.01% | 6526 |
|
|
2019
Q1 | $4K | Hold |
218
| – | – | ﹤0.01% | 6382 |
|
|
2018
Q4 | $3K | Sell |
218
-494
| -69% | -$7.49K | ﹤0.01% | 6391 |
|
|
2018
Q3 | $11K | Buy |
712
+582
| +448% | +$8.32K | ﹤0.01% | 5963 |
|
|
2018
Q2 | $2K | Sell |
130
-104
| -44% | -$1.41K | ﹤0.01% | 6300 |
|
|
2018
Q1 | $3K | Sell |
234
-93
| -28% | -$1.13K | ﹤0.01% | 6075 |
|
|
2017
Q4 | $5K | Sell |
327
-1,691
| -84% | -$24.8K | ﹤0.01% | 6097 |
|
|
2017
Q3 | $34K | Buy |
2,018
+1,833
| +991% | +$29.8K | ﹤0.01% | 5654 |
|
|
2017
Q2 | $3K | Sell |
185
-633
| -77% | -$9.46K | ﹤0.01% | 6216 |
|
|
2017
Q1 | $13K | Sell |
818
-573
| -41% | -$8.18K | ﹤0.01% | 5850 |
|
|
2016
Q4 | $21K | Buy |
+1,391
| New | +$19.5K | ﹤0.01% | 5749 |
|
|
2016
Q1 | – | Sell |
-17
| Closed | – | – | 6792 |
|
|
2015
Q4 | $0 | Sell |
17
-934
| -98% | -$11.6K | ﹤0.01% | 6933 |
|
|
2015
Q3 | $13K | Sell |
951
-162
| -15% | -$2.2K | ﹤0.01% | 5779 |
|
|
2015
Q2 | $15K | Buy |
1,113
+1,002
| +903% | +$13.6K | ﹤0.01% | 5870 |
|
|
2015
Q1 | $2K | Buy |
111
+98
| +754% | +$1.33K | ﹤0.01% | 5924 |
|
|
2014
Q4 | $0 | Buy |
+13
| New | +$178 | ﹤0.01% | 6366 |
|
Royal Bank of Canada's OXFD Position: Q1 2021 in Review
Royal Bank of Canada sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 718 shares — an estimated $13K sold.
Royal Bank of Canada first reported a position in OXFD in Q4 2014 and held it in 22 quarters. The position peaked at $34K in Q3 2017. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Royal Bank of Canada reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Royal Bank of Canada sold 718 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $13K.
- Royal Bank of Canada first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2014 and held it in 22 quarters.
- Royal Bank of Canada's Oxford Immunotec Global PLC Ordinary Shares position peaked at $34K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.